Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study

Gynecol Endocrinol. 2015 May;31(5):406-8. doi: 10.3109/09513590.2015.1006617. Epub 2015 Mar 17.

Abstract

Deep endometriosis involvement of the bladder is uncommon but it is symptomatic in most of the cases. Although laparoscopic excision is very effective, some patients with no pregnancy desire require a medical approach. We performed a pilot study on the effect of a new progestin dienogest on bladder endometriosis. Six patients were treated for 12 months with dienogest 2 mg/daily. Pain, urinary symptoms, quality of life, nodule volume and side effects were recorded. During treatment, symptoms improved very quickly and the nodules exhibit a remarkable reduction in size. Dienogest may be an alternative approach to bladder endometriosis.

Keywords: Deep endometriosis; dienogest; dysuria; pelvic pain.

Publication types

  • Clinical Study

MeSH terms

  • Adult
  • Cohort Studies
  • Dysuria
  • Endometriosis / diagnostic imaging
  • Endometriosis / drug therapy*
  • Female
  • Hematuria
  • Hormone Antagonists / therapeutic use*
  • Humans
  • Nandrolone / analogs & derivatives*
  • Nandrolone / therapeutic use
  • Pilot Projects
  • Quality of Life
  • Treatment Outcome
  • Ultrasonography
  • Urinary Bladder Diseases / diagnostic imaging
  • Urinary Bladder Diseases / drug therapy*

Substances

  • Hormone Antagonists
  • dienogest
  • Nandrolone